Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibacterial Activity of Solid-Supported Gold Nanorods Combined with Antimicrobial Peptides.

ACS applied bio materials·2026
Same author

Role of Defects in Atom Probe Analysis of Sol-Gel Silica.

ACS omega·2025
Same author

Can Ignorance be Bliss and Less be More in Endovascular Aneurysm Repair Surveillance?

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2024
Same author

Photothermal Properties of Solid-Supported Gold Nanorods.

Nano letters·2024
Same author

Silica-embedded Gold Nanoparticles Analyzed by Atom Probe Tomography.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2024
Same author

Aseptic Silk Ligatures Induce Bone Resorption Around Titanium Implants: A 12-Week Pilot Study in Rabbits.

The International journal of oral & maxillofacial implants·2024

Related Experiment Video

Updated: Jun 14, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

Blood interactions with noble metals: coagulation and immune complement activation.

Mats Hulander1, Jaan Hong, Marcus Andersson

  • 1Department of Cell and Molecular Biology/Interface Biophysics, Gothenburg University, Medicinaregatan 9E, 41390 Gothenburg, Sweden. mats.hulander@cmb.gu.se

ACS Applied Materials & Interfaces
|April 2, 2010
PubMed
Summary

Noble metals impact blood compatibility differently. Bactiguard coating showed low thrombogenicity, suggesting nanostructure and combined metal properties are key for biomaterials.

More Related Videos

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Related Experiment Videos

Last Updated: Jun 14, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Area of Science:

  • Biomaterials Science
  • Materials Chemistry
  • Immunology

Background:

  • Noble metals like silver, gold, and palladium are used in biomaterials due to properties like inertness and antimicrobial effects.
  • Early interactions between noble metals and blood are crucial for biomaterial outcomes but are not well-documented.
  • Understanding blood compatibility is vital for developing safe and effective medical implants and devices.

Purpose of the Study:

  • To investigate the early blood reactions, including immune complement activation, thrombin generation, and platelet depletion, upon contact with various noble metals and a nanostructured coating.
  • To compare the blood compatibility of silver (Ag), palladium (Pd), gold (Au), and titanium (Ti) with a commercial Bactiguard coating (Ag, Pd, Au).
  • To explore the relationship between protein adsorption (fibrinogen) and blood responses like thrombogenicity.

Main Methods:

  • Utilized the slide chamber model with whole blood to assess immune complement activation (C3a generation), thrombin/antithrombin (TAT) complex formation, and platelet depletion.
  • Employed quartz crystal microbalance adsorption studies to quantify human fibrinogen deposition on different metal surfaces.
  • Analyzed immune complement factor 3 fragment (C3a) generation and platelet accumulation to evaluate thrombogenic potential.

Main Results:

  • Titanium (Ti) and gold (Au) surfaces showed the highest thrombin/antithrombin (TAT) generation and platelet depletion.
  • Immune complement factor 3 fragment (C3a) generation followed the order: Ag > Au > Pd > Bactiguard > Ti.
  • Fibrinogen adsorption was highest on Ag and lowest on the Bactiguard coating, with no direct correlation to thrombogenicity.

Conclusions:

  • Noble metal chemistry significantly influences protein adsorption and overall blood compatibility.
  • The Bactiguard coating's low thrombogenic response is likely due to a combination of nanostructure and synergistic effects of its constituent metals, not individual properties.
  • Further research into nanostructured coatings is warranted for developing superior blood-compatible biomaterials.